Financial Statements — PYPD
Balance Sheet
(in millions USD)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Cash & Equivalents | 17.45 | 3.08 | 3.40 | 11.64 | 7.45 |
| Total Current Assets | 29.99 | 9.78 | 15.75 | 25.02 | 49.17 |
| Property, Plant & Equipment | 5.34 | 6.81 | 8.53 | 9.18 | 5.73 |
| Total Non-current Assets* | 7.70 | 9.75 | 10.51 | 9.80 | 12.22 |
| Total Assets | 37.69 | 19.53 | 26.26 | 34.82 | 61.40 |
| Total Current Liabilities | 13.16 | 10.29 | 5.45 | 8.70 | 4.32 |
| Long-term Debt | 0.63 | 3.13 | 8.54 | -- | -- |
| Total Non-current Liabilities* | 4.06 | 7.64 | 12.47 | 7.00 | 0.19 |
| Total Liabilities* | 17.21 | 17.93 | 17.92 | 15.71 | 4.51 |
| Retained Earnings | (285.58) | (251.05) | (226.35) | (198.61) | (151.45) |
| Total Stockholder Equity | 20.48 | 1.60 | 8.35 | 19.11 | 56.89 |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Research & Development | 6.22 | 4.76 | 3.96 | 8.40 | 7.44 |
| Selling, General & Admin | 2.49 | 1.10 | 1.50 | 2.24 | 2.45 |
| Operating Income | (9.40) | (6.12) | (5.82) | (11.56) | (10.63) |
| Pretax Income | (9.92) | (6.29) | -- | -- | -- |
| Tax Provision | 0.05 | 0.00 | 0.01 | -- | -- |
| Net Income | (9.98) | (6.29) | (5.84) | (11.84) | (10.48) |
| Basic EPS | 0.78 | 1.25 | 0.13 | 0.61 | 0.56 |
| Diluted EPS | 0.78 | 1.25 | 0.13 | 0.61 | 0.56 |
Cash Flow Statement
(in millions USD)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Operating Cash Flow | (12.71) | (8.49) | (8.28) | (20.34) | (13.55) |
| Capital Expenditures | -- | -- | -- | 1.19 | -- |
| Free Cash Flow* | -- | -- | -- | (21.53) | -- |
| Investing Cash Flow | (12.02) | (6.21) | (7.86) | 9.06 | 15.64 |
| Financing Cash Flow | 26.55 | 12.50 | 10.98 | 13.26 | 1.03 |
* Derived from reported values
